Clinical Trial: A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ?18 Years of Age to <50 Years of Age
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Smallpox
Study Type: INTERVENTIONAL
Official Title: A Randomised, Placebo-Controlled, Dose-Ranging, Observer-Blind Phase 1/2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of mRNA-1769 in Healthy Participants
Brief Summary:
The goal of this study is to assess the safety, tolerability and immunogenicity of mRNA-1769 in healthy adult participants.
Read more